Postnatal phenobarbitone for preventing hyperbilirubinaemia in newborns with ABO incompatibility.
Aggarwal
R
R
Rekha
S
S
D'Souza
F S
FS
D000017:ABO Blood-Group System; D016009:Chi-Square Distribution; D006801:Humans; D006932:Hyperbilirubinemia / Q000517:prevention & control*; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007231:Infant, Newborn; D010634:Phenobarbital / Q000627:therapeutic use*; D011446:Prospective Studies
D000017:ABO Blood-Group System; D006993:Hypnotics and Sedatives; D010634:Phenobarbital